Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5162479 | 1.00 | MEN1 (0.55) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL8057662 | 0.89 | MEN1 (0.39) | MEN1KMT2ATSHRMAPK1HSD17B10 | |
| SCHEMBL8069328 | 0.89 | MEN1 (0.39) | MEN1KMT2ATSHRMAPK1HSD17B10 | |
| SCHEMBL19543462 | 0.88 | MEN1 (0.42) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL28763522 | 0.86 | MEN1 (0.40) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL21069301 | 0.86 | TSHR (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL17656329 | 0.84 | — | — | |
| Tetraethylene Glycol SCHEMBL17006462 | 0.84 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL765642 | 0.84 | — | — | |
| SCHEMBL12527310 | 0.83 | MEN1 (0.42) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118244593-A | Composition for stripping photoresist | 株式会社东进世美肯 | 2024-06-25 | — | — | CN | disclosed |
| CN-117247238-A | Nano lamellar porous calcium hydroxide and preparation method and application thereof | 华北电力大学（保定） | 2023-12-19 | — | — | CN | disclosed |
| CN-116194084-A | Cleavable lipid compounds, compositions containing the same and uses thereof | 赛诺菲巴斯德有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-113614647-A | Resist stripping liquid | 松下知识产权经营株式会社 | 2021-11-05 | — | — | CN | disclosed |
| CN-113614648-A | Resist stripping liquid | 松下知识产权经营株式会社 | 2021-11-05 | — | — | CN | disclosed |
| CN-113614646-A | Resist stripping liquid | 松下知识产权经营株式会社 | 2021-11-05 | — | — | CN | disclosed |
| CN-112912376-A | Proteolytic targeted chimeric (PROTAC) compounds with E3 ubiquitin ligase binding activity and targeting alpha-synuclein for the treatment of neurodegenerative diseases | 阿尔维纳斯运营股份有限公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-108495888-B | Additive mixture for stabilizing polyols and polyurethanes | 巴斯夫欧洲公司 | 2021-03-02 | — | — | CN | disclosed |
| CN-112218859-A | Modulators of proteolysis and related methods of use | 阿尔维纳斯运营股份有限公司 | 2021-01-12 | — | — | CN | disclosed |
| CN-106501043-A | A kind of paraffin section method of effective observation oil palm gynoecium anatomical structure | 中国热带农业科学院椰子研究所 | 2017-03-15 | — | — | CN | disclosed |
| EP-2508544-A1 | Degradable polyacetal polymers | Argon Pharma S.L. (ES) | 2012-10-10 | — | — | EP | disclosed |
| US-8202901-B2 | Compounds that stimulate glucose utilization and methods of use | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2012-06-19 | — | — | US | disclosed |
| CN-102271691-A | Natural silver disinfectant compositions | — | 2011-12-07 | — | — | CN | disclosed |
| US-20090258835-A1 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA TEC EDMONTON (CA) | 2009-10-15 | — | — | US | disclosed |
| US-4508916-A | Curable substituted urethane acrylates | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-04-02 | — | — | US | disclosed |
| US-4477635-A | Polymeric triarylmethane dyes | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258835-A1 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | GPR119, SLC2A4, SLC2A1 | MEN1 3955/4885KMT2A 4588/4885TSHR 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.